Discovery of an ellipticine derivative as TLR3 inhibitor against influenza A virus and SARS-CoV-2
Description
Influenza and COVID-19 continue to pose global threats to public health. Classic antiviral drugs have certain limitations, coupled with frequent viral mutations leading to many drugs being ineffective, the development of new antiviral drugs is urgent
